Neurovascular Embolization Market
Neurovascular Embolization Market Forecasts to 2030 - Global Analysis By Product (Flow Diversion Devices, Aneurysm Clips, Embolic Coils, Liquid Embolic Agents/Systems and Other Products), Procedure (Arteriovenous Malformation (AVM) Embolization, Aneurysm Coiling and Embolization and Other Procedures), End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $1.52 BN |
|
Projected Year Value (2030) |
US $2.67 BN |
|
CAGR (2023 - 2030) |
8.4% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
Europe |
According to Stratistics MRC, the Global Neurovascular Embolization Market is accounted for $1.52 billion in 2023 and is expected to reach $2.67 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Neurovascular embolization is a medical procedure used to treat various conditions affecting the blood vessels of the brain and nervous system. It involves the intentional introduction of embolic agents, such as particles, coils, or liquid substances, into the blood vessels to block or reduce blood flow to targeted areas employed to treat abnormal vascular structures. Furthermore, by occluding or reducing blood flow to the affected vessels, neurovascular embolization helps to alleviate symptoms, prevent further damage, and promote overall vascular stability.
According to the Brain Aneurysms Foundation, in the U.S., roughly 6.7 million people have unruptured brain aneurysms, leading to an annual rupture rate of 8-10 cases per 100,000.
Market Dynamics:
Driver:
Expansion of Healthcare Infrastructure
The expansion of healthcare infrastructure facilitates collaborative efforts between healthcare institutions, industry stakeholders, and regulatory bodies, fostering research and development initiatives. This expansion not only addresses the growing burden of neurovascular disorders but also enables timely diagnosis and intervention. Moreover, a collaborative environment supports the continuous improvement of embolic materials, delivery systems, and procedural techniques, contributing to the overall advancement of the neurovascular embolization field.
Restraint:
Limited awareness and education
The limited awareness can lead to underutilization of neurovascular embolization, with patients being directed towards alternative treatments. Lack of public education campaigns and information dissemination about the procedure can result in delayed diagnosis and treatment. Furthermore, the complexity of neurovascular embolization and the specialized skills required to perform the procedure can be a barrier to its widespread adoption, which is impeding this market expansion.
Opportunity:
Technological advancements
The advancements in technology and innovations in embolic materials, delivery systems, and imaging technologies have significantly improved the precision, safety, and efficacy of neurovascular embolization procedures. Advanced delivery systems, including microcatheters and navigation tools, enable neurointerventionalists to reach intricate vascular structures. Furthermore, the integration of artificial intelligence (AI) and machine learning further refines procedural planning and execution, optimizing outcomes and reducing procedural times, which drive this market growth.
Threat:
Economic downturns
Economic downturns impact patients' ability to afford neurovascular embolization procedures and often face constraints and cost-cutting measures. This can lead to a reduction in funding for medical procedures, and individuals may face challenges in securing adequate health insurance coverage or may have limited resources. Additionally, economic downturns can disrupt the overall healthcare ecosystem, including physician practices and referral patterns. Physicians may experience reduced patient volumes or changes, which are hampering this market.
Covid-19 Impact
The COVID-19 pandemic has had several negative impacts on the neurovascular embolization market. The pandemic led to disruptions in healthcare services globally, procedures including certain neurovascular interventions like embolization, which were deferred or cancelled, impacting the overall procedural volume. Logistic challenges also impacted the availability of medical devices, including those used in neurovascular embolization. In addition, the shift in healthcare priorities and the financial strain on healthcare systems also hindered this market size.
The embolic coils segment is expected to be the largest during the forecast period
The embolic coil segment is estimated to hold the largest share due to its focus on the treatment of vascular abnormalities in the brain. This technique involves the deployment of platinum or other biocompatible coils through a catheter directly into the blood vessel. These coils induce clot formation, promoting the natural healing process and preventing the risk of rupture. In addition, it is versatile in treating cerebrovascular conditions, including aneurysms and arteriovenous malformations, coupled with ongoing research and development efforts that are boosting this segment’s expansion.
The aneurysm coiling and embolization segment is expected to have the highest CAGR during the forecast period
The aneurysm coiling and embolization segment is anticipated to have highest CAGR during the forecast period. It is a crucial intervention for treating vascular abnormalities in the brain, wherein a catheter is navigated through blood vessels to the site of the aneurysm. Platinum coils or other embolic devices are then deployed into the aneurysm, promoting blood clot formation and preventing rupture. Furthermore, aneurysm coiling and embolization procedures offer reduced invasiveness, shorter recovery times, and a lower risk of complications, and rising awareness among both healthcare providers and patients contributes to the sustained growth of this market.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period, owing to increased demand and advancements in healthcare infrastructure. Increasing healthcare awareness, improved diagnostic capabilities, and expanding access to healthcare services have heightened the demand for neurovascular embolization procedures. Furthermore, collaborative efforts between healthcare institutions and industry players have resulted in the development and introduction of innovative embolic materials and devices, which are driving this region’s growth.
Region with highest CAGR:
Europe is expected to witness highest CAGR over the projection period, owing to a growing awareness of advanced neurointerventional procedures, including embolization. Key players such as Medtronic plc, Penumbra, Inc., MicroVention, and Acandis GmbH continue to evolve technological advancements in healthcare systems, contributing to improved patient outcomes. Furthermore, increasing incidences of cerebrovascular diseases, such as aneurysms and arteriovenous, are propelling this region’s expansion.
Key players in the market
Some of the key players in the Neurovascular Embolization Market include Cerenovus, Penumbra Inc, Medtronic, Phenox GmbH, Stryker, Balt SAS, Shape Memory Medical Inc, Integra LifeSciences, B. Braun Melsungen AG, MicroVention Inc, Peter Lazic GmbH and Spartan Micro.
Key Developments:
In August 2023, Medtronic announced the outcome of the U.S. Food & Drug Administration (FDA) Circulatory System Devices Panel (CSDP) meeting to review data presented in support of the Medtronic Symplicity Spyral™ Renal Denervation (RDN) System.
In February 2022, CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices Companies,* announced the launch of EMBOGUARD™, a next generation balloon guide catheter to be used in endovascular procedures, including those for patients with acute ischemic stroke.
In June 2021, Johnson & Johnson Medical Devices Companies* announced the first patient was enrolled in the CERENOVUS-sponsored MEMBRANE study evaluating TruFill® n-BCA Liquid Embolic System in the embolization of middle meningeal artery (MMA) for treatment of chronic subdural hematoma (cSDH) as adjunct to surgical evacuation or as a stand-alone treatment.
In January 2020, MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Approval (PMA) for the FRED® (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms.
Products Covered:
• Flow Diversion Devices
• Aneurysm Clips
• Embolic Coils
• Liquid Embolic Agents/Systems
• Other Products
Procedures Covered:
• Arteriovenous Malformation (AVM) Embolization
• Aneurysm Coiling and Embolization
• Other Procedures
End Users Covered:
• Specialty Clinics
• Hospitals
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Neurovascular Embolization Market, By Product
5.1 Introduction
5.2 Flow Diversion Devices
5.3 Aneurysm Clips
5.4 Embolic Coils
5.5 Liquid Embolic Agents/Systems
5.6 Other Products
6 Global Neurovascular Embolization Market, By Procedure
6.1 Introduction
6.2 Arteriovenous Malformation (AVM) Embolization
6.3 Aneurysm Coiling and Embolization
6.4 Other Procedures
7 Global Neurovascular Embolization Market, By End User
7.1 Introduction
7.2 Specialty Clinics
7.3 Hospitals
7.4 Other End Users
8 Global Neurovascular Embolization Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Cerenovus
10.2 Penumbra Inc
10.3 Medtronic
10.4 Phenox GmbH
10.5 Stryker
10.6 Balt SAS
10.7 Shape Memory Medical Inc
10.8 Integra LifeSciences
10.9 B. Braun Melsungen AG
10.10 MicroVention Inc
10.11 Peter Lazic GmbH
10.12 Spartan Micro
List of Tables
1 Global Neurovascular Embolization Market Outlook, By Region (2021-2030) ($MN)
2 Global Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
3 Global Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
4 Global Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
5 Global Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
6 Global Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
7 Global Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
8 Global Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
9 Global Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
10 Global Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
11 Global Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
12 Global Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
13 Global Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
14 Global Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
15 Global Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
16 North America Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
17 North America Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
18 North America Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
19 North America Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
20 North America Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
21 North America Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
22 North America Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
23 North America Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
24 North America Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
25 North America Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
26 North America Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
27 North America Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
28 North America Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
29 North America Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
30 North America Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
31 Europe Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
32 Europe Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
33 Europe Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
34 Europe Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
35 Europe Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
36 Europe Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
37 Europe Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
38 Europe Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
39 Europe Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
40 Europe Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
41 Europe Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
42 Europe Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
43 Europe Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
44 Europe Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
45 Europe Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
46 Asia Pacific Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
47 Asia Pacific Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
48 Asia Pacific Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
49 Asia Pacific Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
50 Asia Pacific Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
51 Asia Pacific Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
52 Asia Pacific Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
53 Asia Pacific Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
54 Asia Pacific Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
55 Asia Pacific Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
56 Asia Pacific Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
57 Asia Pacific Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
58 Asia Pacific Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
59 Asia Pacific Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
60 Asia Pacific Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
61 South America Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
62 South America Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
63 South America Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
64 South America Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
65 South America Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
66 South America Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
67 South America Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
68 South America Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
69 South America Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
70 South America Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
71 South America Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
72 South America Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
73 South America Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
74 South America Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
75 South America Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
76 Middle East & Africa Neurovascular Embolization Market Outlook, By Country (2021-2030) ($MN)
77 Middle East & Africa Neurovascular Embolization Market Outlook, By Product (2021-2030) ($MN)
78 Middle East & Africa Neurovascular Embolization Market Outlook, By Flow Diversion Devices (2021-2030) ($MN)
79 Middle East & Africa Neurovascular Embolization Market Outlook, By Aneurysm Clips (2021-2030) ($MN)
80 Middle East & Africa Neurovascular Embolization Market Outlook, By Embolic Coils (2021-2030) ($MN)
81 Middle East & Africa Neurovascular Embolization Market Outlook, By Liquid Embolic Agents/Systems (2021-2030) ($MN)
82 Middle East & Africa Neurovascular Embolization Market Outlook, By Other Products (2021-2030) ($MN)
83 Middle East & Africa Neurovascular Embolization Market Outlook, By Procedure (2021-2030) ($MN)
84 Middle East & Africa Neurovascular Embolization Market Outlook, By Arteriovenous Malformation (AVM) Embolization (2021-2030) ($MN)
85 Middle East & Africa Neurovascular Embolization Market Outlook, By Aneurysm Coiling and Embolization (2021-2030) ($MN)
86 Middle East & Africa Neurovascular Embolization Market Outlook, By Other Procedures (2021-2030) ($MN)
87 Middle East & Africa Neurovascular Embolization Market Outlook, By End User (2021-2030) ($MN)
88 Middle East & Africa Neurovascular Embolization Market Outlook, By Specialty Clinics (2021-2030) ($MN)
89 Middle East & Africa Neurovascular Embolization Market Outlook, By Hospitals (2021-2030) ($MN)
90 Middle East & Africa Neurovascular Embolization Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
